With the progressive increase in life-expectancy of human immunodeficiency virus (HIV)-
positive patients in the “highly active antiretroviral therapy”(HAART) era, co-morbidities …

The introduction of potent combination antiretroviral therapy (cART) has had a remarkable
impact on the natural history of HIV infection, leading to a dramatic decline in the mortality …

Effective highly active antiretroviral therapy (HAART) for human immunodeficiency virus-1
(HIV) infection has led to marked improvement in life-expectancy for those infected with HIV …

Since the discovery and development of antiretroviral therapy (ART), HIV has become a
chronic disease with patients living longer lives and to ages where co‐morbidities, such as …

Background: The prevalence of atherosclerosis is higher in HIV-positive people, who also
experience it earlier than the general population. Objectives: To assess and compare the …

Insulin resistance (IR) was one of the first metabolic complications reported with highly
active antiretroviral therapy for HIV infection. It continues to be of concern despite the …

Infection with human immunodeficiency virus (HIV) and treatment with HIV-protease inhibitor
(PI)-based highly active antiretroviral therapies (HAART) is associated with dysregulated …

Ethnopharmacological relevance Due to the development of antiretroviral therapy (ART),
HIV/AIDS is now regarded as a treatable chronic disease. Chinese herbal medicine (CHM) …

Protease inhibitors are still a cornerstone of combination antiretroviral therapy. A profound
knowledge of the unwanted, but manageable, effects of protease inhibitor therapy is …

Many infections favor or are directly implicated with lipid metabolism perturbations and/or
increased risk of coronary heart disease (CHD). HIV itself has been shown to increase …